Detailed answers about DRUG DEVELOPMENT COMPANY LIMITED, including incorporation, status, business activity, and accounts information.
When was DRUG DEVELOPMENT COMPANY LIMITED founded?
DRUG DEVELOPMENT COMPANY LIMITED was officially incorporated on 31 May 2017 and is registered under company number 10795275. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DRUG DEVELOPMENT COMPANY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DRUG DEVELOPMENT COMPANY LIMITED?
DRUG DEVELOPMENT COMPANY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DRUG DEVELOPMENT COMPANY LIMITED do?
DRUG DEVELOPMENT COMPANY LIMITED operates in the following sector: 82990 - Other business support service activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is DRUG DEVELOPMENT COMPANY LIMITED's registered address?
The registered office address of DRUG DEVELOPMENT COMPANY LIMITED is 2ND FLOOR GODFREE COURT, APEX YARD, 29 LONG LANE, LONDON, UNITED KINGDOM, SE1 4PL. This is the official address filed with Companies House for legal and statutory correspondence.
Is DRUG DEVELOPMENT COMPANY LIMITED financially stable?
The most recent accounts for DRUG DEVELOPMENT COMPANY LIMITED were made up to 30 November 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 29 August 2026.